![Two men, seated indoors around a table, engaged in a conversation and playing chess Two men, seated indoors around a table, engaged in a conversation and playing chess](/sites/novartis_com/files/styles/cards_1_3/public/2023-11/young-and-senior-men-playing-chess-and-laughing.jpg.webp?itok=UnOb1uRr)
Discover our medicines
Our innovative medicines address society’s greatest disease burdens and restore possibility for patients.
![A female research scientist in a lab looking at a sample A female research scientist in a lab looking at a sample](/sites/novartis_com/files/styles/cards_1_3/public/2023-11/portrait-research-scientist-cambridge.jpg.webp?itok=VsWfrp88)
Explore our science
Discover how we unravel the mysteries of biology and develop new technologies to fight disease and change lives.
![Group of warm clothed women, seated outside, smiling and laughing Group of warm clothed women, seated outside, smiling and laughing](/sites/novartis_com/files/styles/cards_1_3/public/2023-11/group-of-warm-clothed-people-smilling-and-laughing.jpg.webp?itok=A3aS2xa7)
Learn about our impact
Creating a medicine is just the beginning of the journey. Discover how we embrace societal impact as a core business objective.
![Q1 2024 Q1 2024](/sites/novartis_com/files/styles/cta_image/public/2024-04/novartis-q1-2024-lp.png.webp?itok=1QMu5xao)
Novartis Financial Results – Q1 2024
Novartis announced the company’s financial results for the first quarter of 2024.
Latest news
Novartis and Medicines for Malaria Venture announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria
Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors
Novartis delivers double-digit sales growth and core margin expansion in Q1; FY 2024 guidance raised
The burden of IgAN
IgAN nephropathy (IgAN) is a heterogeneous, progressive, rare kidney disease and is a major cause of chronic kidney disease worldwide. Novartis is working to slow the progression of this disease and extend a dialysis-free life in patients.
![Shanelle Gabriel spending time with her father in New York Shanelle Gabriel spending time with her father in New York](/sites/novartis_com/files/styles/cta_image/public/2024-01/shanelle-gabriel-sitting-on-bench-with-her-father-new-york.jpg.webp?itok=rgMBxoxt)
Novartis in Society Integrated Report 2023
Learn about our business, strategy and performance in 2023, and how we create sustainable value for stakeholders and society.